Wellgistics Health Inc.

NASDAQ: WGRX · Real-Time Price · USD
2.39
-0.09 (-3.63%)
At close: May 23, 2025, 3:59 PM
2.34
-2.07%
After-hours: May 23, 2025, 04:15 PM EDT

Company Description

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products.

It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.

It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.

The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.

Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Wellgistics Health Inc.
Wellgistics Health Inc. logo
Country United States
IPO Date Feb 25, 2025
Industry Medical - Distribution
Sector Healthcare
Employees 31
CEO Brian Leonard Norton

Contact Details

Address:
3000 Bayport Drive
Tampa, Florida
United States
Website https://www.wellgisticshealth.com

Stock Details

Ticker Symbol WGRX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002030763
CUSIP Number n/a
ISIN Number US9495031067
Employer ID 93-3264234
SIC Code 5122

Key Executives

Name Position
Brian Leonard Norton Chief Executive Officer
David Madsen Chief Operating Officer
Mark DiSiena CPA, M.B.A. Chief Financial Officer
Srinivas Kalla Chief Information Officer
Dr. Shafaat Pirani Pharm.D. Chief Clinical Officer & Executive Vice President of Healthcare Operations
Prashant Patel R.Ph. Chief Strategy Officer & Vice Chairman of the Board

Latest SEC Filings

Date Type Title
May 15, 2025 8-K Current Report
May 12, 2025 10-Q Quarterly Report
May 07, 2025 EFFECT Filing
May 07, 2025 424B3 Filing
May 05, 2025 S-1 Filing
Apr 24, 2025 8-K Current Report
Apr 24, 2025 3 Filing
Apr 23, 2025 3 Filing
Apr 18, 2025 8-K Current Report
Apr 15, 2025 DRS Filing